• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清神经丝轻链在预测糖尿病多发性神经病患者疼痛严重程度方面的作用有限。

The limited role of serum neurofilament light chain in predicting pain severity of patients with diabetic polyneuropathy.

机构信息

Department of Family Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, South Korea.

Department of Neurology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 680 Gukchaebosang-ro, Jung-gu, Daegu, 41944, South Korea.

出版信息

Sci Rep. 2024 Jul 6;14(1):15612. doi: 10.1038/s41598-024-66444-9.

DOI:10.1038/s41598-024-66444-9
PMID:38971890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11227535/
Abstract

Pain is one of many complaints expressed by patients with diabetic polyneuropathy. However, no objective measure for pain severity has been available. Neurofilament light chains have been widely used for assessing axonal damage in the neuronal system. Hence, we sought to investigate whether neurofilament light chains can serve as a marker reflecting pain severity in diabetic polyneuropathy. We enrolled the patients with diabetic polyneuropathy. Serum concentrations of neurofilament light chain were then measured using a single-molecule array. Pain severity was evaluated using painDETECT and the Brief Pain Inventory. Moreover, laboratory results including, serum creatinine, HbA1c, and glomerular filtration rate. A correlation test was used to analyze each variable. A total of 42 patients were enrolled. Neurofilament light chain levels were unable to reflect current neuropathic pain severity. However, high levels of neurofilament light chain were a significant predictor of poor diabetes control (r = 0.41; p = 0.02) and kidney damage (r = 0.45; p = 0.01). Serum levels of neurofilament light chain could not reflect current pain severity but was strongly associated with kidney dysfunction and poor diabetes control. Other biomarkers that could predict pain severity need to be uncovered.

摘要

疼痛是糖尿病多发性神经病患者表达的众多抱怨之一。然而,一直没有客观的疼痛严重程度衡量标准。神经丝轻链已广泛用于评估神经元系统中的轴突损伤。因此,我们试图研究神经丝轻链是否可以作为反映糖尿病多发性神经病疼痛严重程度的标志物。我们招募了糖尿病多发性神经病患者。然后使用单分子阵列测量血清神经丝轻链浓度。使用疼痛 DETECT 和简明疼痛量表评估疼痛严重程度。此外,实验室结果包括血清肌酐、HbA1c 和肾小球滤过率。使用相关测试分析每个变量。共纳入 42 例患者。神经丝轻链水平无法反映当前的神经性疼痛严重程度。然而,神经丝轻链水平高是糖尿病控制不良(r=0.41;p=0.02)和肾脏损伤(r=0.45;p=0.01)的显著预测指标。血清神经丝轻链水平不能反映当前的疼痛严重程度,但与肾功能障碍和糖尿病控制不良密切相关。需要发现其他可以预测疼痛严重程度的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f3/11227535/e4d3cef5ecc3/41598_2024_66444_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f3/11227535/e4d3cef5ecc3/41598_2024_66444_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70f3/11227535/e4d3cef5ecc3/41598_2024_66444_Fig1_HTML.jpg

相似文献

1
The limited role of serum neurofilament light chain in predicting pain severity of patients with diabetic polyneuropathy.血清神经丝轻链在预测糖尿病多发性神经病患者疼痛严重程度方面的作用有限。
Sci Rep. 2024 Jul 6;14(1):15612. doi: 10.1038/s41598-024-66444-9.
2
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.血清神经丝轻链:早期糖尿病感觉运动多发性神经病的新型生物标志物。
Diabetologia. 2023 Mar;66(3):579-589. doi: 10.1007/s00125-022-05846-8. Epub 2022 Dec 6.
3
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.血清神经丝作为多发性硬化症疾病恶化和脑脊髓萎缩的预测指标。
Brain. 2018 Aug 1;141(8):2382-2391. doi: 10.1093/brain/awy154.
4
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.验证 DN4 作为一种筛查工具用于诊断痛性糖尿病多发性神经病中的神经性疼痛。
Diabet Med. 2012 May;29(5):578-85. doi: 10.1111/j.1464-5491.2011.03500.x.
5
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.神经丝轻链:化疗诱导周围神经毒性大鼠模型中轴突损伤严重程度的特异性血清生物标志物。
Arch Toxicol. 2020 Jul;94(7):2517-2522. doi: 10.1007/s00204-020-02755-w. Epub 2020 Apr 24.
6
Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.2 型糖尿病及早期糖尿病多发性神经病患者血清神经丝轻链的纵向变化:ADDITION-丹麦研究。
Diabetes Care. 2024 Jun 1;47(6):986-994. doi: 10.2337/dc23-2208.
7
Cytokine Levels in Neural Pain in Leprosy.麻风病神经痛中的细胞因子水平。
Front Immunol. 2020 Jan 24;11:23. doi: 10.3389/fimmu.2020.00023. eCollection 2020.
8
Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus.台湾2型糖尿病成年患者中伴或不伴神经性疼痛的糖尿病周围神经病变的患病率及生化危险因素
Diabetes Metab Syndr. 2018 Apr-Jun;12(2):111-116. doi: 10.1016/j.dsx.2017.09.013. Epub 2017 Sep 28.
9
Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.神经元特异性生物标志物可预测糖尿病周围神经病变患者的痛觉过敏和痛觉减退。
Diabetologia. 2021 Dec;64(12):2843-2855. doi: 10.1007/s00125-021-05557-6. Epub 2021 Sep 3.
10
Serum brain-derived neurotrophic factor levels in patients with diabetic neuropathic pain.糖尿病性神经病理性疼痛患者的血清脑源性神经营养因子水平。
Neurosci Lett. 2021 May 1;752:135655. doi: 10.1016/j.neulet.2021.135655. Epub 2021 Jan 21.

引用本文的文献

1
Clinical Phenotypes of Diabetic Peripheral Neuropathy: Implications for Phenotypic-Based Therapeutics Strategies.糖尿病周围神经病变的临床表型:对基于表型的治疗策略的启示
Diabetes Metab J. 2025 Jul;49(4):542-564. doi: 10.4093/dmj.2025.0299. Epub 2025 Jul 1.
2
A scoring model integrating CXCL9, GDF15, FGF21, and NfL, predicts long-term mortality in type 2 diabetes: a retrospective study.整合CXCL9、GDF15、FGF21和NfL的评分模型预测2型糖尿病的长期死亡率:一项回顾性研究
Cardiovasc Diabetol. 2025 Jul 8;24(1):270. doi: 10.1186/s12933-025-02830-5.
3
Crumbling Pathogenesis and Biomarkers for Diabetic Peripheral Neuropathy.

本文引用的文献

1
Association of neurofilament light chain with renal function: mechanisms and clinical implications.神经丝轻链与肾功能的关联:机制与临床意义。
Alzheimers Res Ther. 2022 Dec 16;14(1):189. doi: 10.1186/s13195-022-01134-0.
2
Diabetes Mellitus is Associated With Higher Serum Neurofilament Light Chain Levels in the General US Population.在美国普通人群中,糖尿病与较高的血清神经丝轻链水平相关。
J Clin Endocrinol Metab. 2023 Jan 17;108(2):361-367. doi: 10.1210/clinem/dgac580.
3
Which scale is more useful to detect diabetic neuropathic pain?: A cross-sectional study.
糖尿病周围神经病变的发病机制及生物标志物研究进展
Biomedicines. 2025 Feb 8;13(2):413. doi: 10.3390/biomedicines13020413.
哪种量表更有助于检测糖尿病性神经病理性疼痛?:一项横断面研究。
BMC Endocr Disord. 2022 Mar 7;22(1):56. doi: 10.1186/s12902-022-00970-3.
4
Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: A case series.循环神经丝对婴儿期脊髓性肌萎缩症治疗的影响:病例系列。
Mol Ther Methods Clin Dev. 2021 Oct 30;23:524-538. doi: 10.1016/j.omtm.2021.10.011. eCollection 2021 Dec 10.
5
Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice.健康个体的血清神经丝轻链水平:在多发性硬化症临床实践中使用的截断值建议。
Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
6
Renal function is associated with blood neurofilament light chain level in older adults.肾功能与老年人血液神经丝轻链水平有关。
Sci Rep. 2020 Nov 23;10(1):20350. doi: 10.1038/s41598-020-76990-7.
7
The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises.修订后的国际疼痛研究协会疼痛定义:概念、挑战和妥协。
Pain. 2020 Sep 1;161(9):1976-1982. doi: 10.1097/j.pain.0000000000001939.
8
Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels.神经丝在神经系统疾病患者中的水平:神经丝轻链和重链水平的比较。
J Clin Lab Anal. 2019 Sep;33(7):e22948. doi: 10.1002/jcla.22948. Epub 2019 Jun 14.
9
Diabetic neuropathy.糖尿病性神经病。
Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1.
10
Neurofilament as a potential biomarker for spinal muscular atrophy.神经丝作为脊髓性肌萎缩症的潜在生物标志物。
Ann Clin Transl Neurol. 2019 Apr 17;6(5):932-944. doi: 10.1002/acn3.779. eCollection 2019 May.